Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) — Free Cash Flow Generation Index

Latest as of September 2024: 0.91x

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has a Free Cash Flow Generation Index of 0.91x as of September 2024. Free cash flow of TL30.46 Million represents 1% of operating cash flow (TL33.37 Million). Explore Oncosem Onkolojik Sistemler Sanayi ve Ti capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.91x
Free Cash Flow / Operating CF

Free Cash Flow

TL30.46 Million
TRY

Operating Cash Flow

TL33.37 Million
TRY

Capital Expenditures

TL2.91 Million
TRY

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Free Cash Flow Generation Index (2020–2022)

Historical FCF Generation Index trend for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. across 3 annual periods. For the full cash flow conversion analysis, see Oncosem Onkolojik Sistemler Sanayi ve Ti (ONCSM) cash conversion ratio.

Annual Free Cash Flow Generation for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2022)

Year-by-year Free Cash Flow Generation Index for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.. Check Oncosem Onkolojik Sistemler Sanayi ve Ti (ONCSM) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (TRY) Operating CF Capital Expenditures YoY Change
2022 0.51x TL26.67 Million TL52.69 Million TL26.02 Million ▼ -49.4%
2021 1.00x TL51.68 Million TL51.68 Million TL0.00 ▲ +0.0%
2020 1.00x TL19.41 Million TL19.41 Million TL0.00
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).